This AST SpaceMobile Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Analysts downgraded several companies: Foghorn Therapeutics (FHTX) to Neutral, First Busey (BUSE) to Neutral with a $30 target, AST SpaceMobile (ASTS) to Neutral with a $65 target, AtriCure (ATRC) to Hold with a $57 target, and Equity Bancshares (EQBK) to Neutral with a $52 target. ASTS closed at $57.04 on Thursday.
How this was made
The 30-second read
Why it matters
The collective downgrades signal a broader shift in analyst sentiment, which can lead to sector‑wide re‑pricing.
Market read
Multiple downgrades across diverse industries may prompt short‑term volatility and influence risk sentiment.
What to watch
Potential upcoming catalysts (clinical data, earnings) could offset the downgrade impact.
Background
Analyst rating changes are a common catalyst for short‑term price moves, especially when accompanied by target adjustments.
Ticker impact
AST SpaceMobile was downgraded by B. Riley from Buy to Neutral with a price target cut to $65.
likely downward pressure as investors price in the lower target
Analyst cut target by $20 and changed rating, indicating reduced confidence in near‑term performance.
Foghorn Therapeutics was downgraded by BTIG from Buy to Neutral.
potential modest decline as market absorbs downgrade
Rating downgrade without target change still signals reduced upside.
First Busey Corp was downgraded by Piper Sandler from Overweight to Neutral with target cut to $30.
downward pressure as investors adjust expectations
Both rating and price target were reduced, indicating weaker outlook.
AtriCure was downgraded by B. Riley from Buy to Hold and target raised to $57.
limited impact; price may stabilize
Target increase offsets rating downgrade, creating mixed signals.
Equity BancShares was downgraded by Piper Sandler from Overweight to Neutral with target cut to $52.
likely modest decline as market reassesses valuation
Both rating and target were reduced, indicating a less favorable view.
Market effects
Analyst downgrades across biotech, banking and satellite sectors may temper sector sentiment.
U.S. equity markets may see slight pullback in related subsectors.
Limited; primarily affects U.S.-listed companies.
Counterpoint
Some investors may view the downgrades as overreactions and look for buying opportunities on the dip.
Key entities
- analyst firmB. Riley Securities
Provided downgrade for ASTS and ATRC.
- analyst firmBTIG
Downgraded FHTX.
- analyst firmPiper Sandler
Downgraded BUSE and EQBK.
